ReviewMetabolism: clinical and experimental2019

Initial injectable therapy in type 2 diabetes: Key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulin.

Anastasia-Stefania Alexopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.